Latest Whitepapers

This app note presents a novel protocol for generating larger quantities of invariant NK (iNK) cells from pluripotent stem cells (PSCs) using cytokine cocktails.

In this article to learn more about detecting contamination during bioprocessing, contamination’s influence on product quality and safety and emerging methods for detecting microbial contaminations.

This whitepaper explores groundbreaking organ-on-a-chip technology and 3D tissue modeling that is closing the translational gap in cancer drug discovery.

This whitepaper explores three unique case studies, showing how TEMs can be applied in diagnostics. Learn how to fine tune pore size and density to reliably capture target cells, ensure quality manufacturing and benefit downstream analysis.

This article explores how we can find new ways to stop tumor growth and prevent drug resistance by targeting the language of cancer cell communication.

As biopharmaceutical companies scale up manufacturing, many are turning to outsourcing for buffer and process liquid preparation. But before making this decision, organizations must carefully weigh up various factors, including manufacturing space, personnel requirements and analytical capabilities.

This brochure explores the applications of a real-time metabolic analysis platform for cancer research and cell therapeutics development.

This article explores how quality control can improve protocol standardization, enhance scalability and ensure that cultures meet regulatory criteria.

One factor that can significantly impact the success of oncology drug development is the preclinical model used. The right model can provide valuable insights into key interactions within the body and help researchers to better understand how tumors respond to treatment.

This whitepaper highlights the latest bioprocessing film technologies to help you meet your upstream and downstream needs.